Skip to content

ZION

NASDAQ

Zions Bancorporation NA

Financials
Banking

$69.75

1.7%

Updated Today 11:10 AM ET

Report Card

ZION at a glance — five pillars scored 0–100 from real filed financials.

Value
Growth
Profitability
Health
Dividends
0

Overall: Unrated · 0/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.

Key Metrics

Market Cap

$0.00

P/E

Forward P/E (est.)

ROE

Revenue Growth

EPS Growth

Profit Margin

FCF Yield

Debt / Equity

ROIC

Interest Coverage

Current Ratio

Dividend Yield

Implied Growth (rev. DCF)

Rating Score

0/100

Business Overview
Research

Zions Bancorporation NA (ZION) is a small-cap company in the Banking industry, part of the Financials sector of the S&P 500.

In its latest reported year it generated about $529.00M in revenue and $899.00M in net profit.

Our model rates ZION Unrated (0/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.

Revenue Growth
Research

4Y CAGR

4.2%

Revenue moved from $412.00M in 2018 to $529.00M in 2025, a 3.6% compound annual growth rate. The most recent year was roughly steady year over year. Slower, mature growth is common for established businesses.

Profitability

Gross Margin

Operating Margin

Net Margin

169.9%

ROE

Debt Analysis
Research

Total Debt

$946.00M

Net Debt

$946.00M

Net Debt / EBITDA

Debt / Equity

Leverage: debt-to-equity is n/a. Detailed balance-sheet leverage is limited for this name.

Cash Flow Analysis
Research

Operating CF

$1.07B

Free Cash Flow

$952.00M

FCF Margin

180.0%

In the latest year Zions Bancorporation NA produced about $1.07B of operating cash flow and $952.00M of free cash flow after capital spending. Cash flow is what ultimately pays shareholders, so it is worth tracking over time.

Dividend Safety

Can the payout survive a bad year? Scored from filed cash flow, earnings coverage, and the raise/cut record.

BorderlineSafety score: 55/100

The dividend is being paid, but coverage or consistency is thinner than an income investor should rely on without a closer look.

Per share (latest FY)

$1.76

Total paid (latest FY)

$267.00M

History on record

8 years

Free-cash-flow coverage100/100

dividend uses 28% of free cash flow

Earnings payout ratio100/100

30% of net income paid out

Raise streak0/100

no current raise streak

Cut history0/100

payout was cut at least once in the last 8 years

Coverage uses the latest fiscal year as filed with the SEC; the streak counts total dollars paid (per-share figures can carry split artifacts). Educational information, not income advice.

Valuation Analysis
Research
1/1 checks passedTrading below DCF fair value

P/E

P/S

P/B

EV / EBITDA

ZION trades at n/a trailing earnings. With no positive trailing earnings, value it on sales, cash flow, or growth rather than P/E.

DCF Fair Value (Educational)

A two-stage discounted cash flow on real SEC-filed free cash flow — the intrinsic-value anchor professional analysts triangulate from.

DCF fair value / share

$111.99

Current price

$69.75

+61% · Below fair-value estimate

Starting FCF (latest 10-K)

$952.00M

Growth, years 1–5

4.0%

Fade to terminal, years 6–10

2.5%

Discount rate

9.0%

PV of 10-yr free cash flow$7.36B
PV of terminal value$8.99B
Estimated equity value$16.35B
Shares outstanding146M

Cash flows grow at the stage-1 rate (trailing revenue growth, capped at 20%) for five years, fade to 2.5% by year 10, and continue at that rate forever (Gordon terminal value), all discounted at 9.0%. Small changes in assumptions move the result a lot — treat this as one reference point, not a target price. Educational only, not investment advice.

Metrics vs. Sector Range

Where ZION sits versus its Financials sector peers in the S&P 500.

TTM P/E
Forward P/E
P/S ratio
Revenue growth
EPS growth
Gross margin
Net margin
ROE

Bands show the middle half (25th–75th percentile) of the 141 Financials companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.

Sector Peer Comparison

How ZION stacks up against its Financials peers — valuation, profitability, and growth versus the sector median.

In the Financials sector (289 S&P 500 companies), ZION ranks #289 of 289 by our overall rating.

P/E vs sector

median 15.6x

ROE vs sector

median 13.6%

Growth vs sector

median 15.9%

Sector rank

#289

of 289 by rating

CompanyP/ERev Gr.Rating
ZIONThis stockNot rated
AMALNot rated
BANFNot rated
BANRNot rated
BFCNot rated
BFSTNot rated
BHRBNot rated
BOKFNot rated
Financials median15.6x15.9%0/100
Compare side by side

Peers are the closest Financials companies by sub-industry and size. Sector median is across all 289 S&P 500 names in the sector. Educational, not a recommendation.

5-Year Projection Model

Project revenue → earnings → price. Edit the assumptions to build your own case.

2030 price target (Base Case)

$0.00 $0.00

vs. $69.75 today · expected CAGR -14%-5%

Metric20262027202820292030
Revenue$571.32M$617.03M$666.39M$719.70M$777.27M
Net income$285.66M$308.51M$333.19M$359.85M$388.64M
EPS$1.96$2.11$2.28$2.47$2.66
Share price (low)$23.49$25.37$27.39$29.59$31.95
Share price (high)$39.14$42.28$45.66$49.31$53.25
CAGR (low–high)-66% / -44%-40% / -22%-27% / -13%-19% / -8%-14% / -5%

Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.

Bull Case

The case for ZION:

  • As an established S&P 500 member in Financials, it brings scale and a long operating history.
Bear Case

The case against ZION:

  • Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Key Risks
Research

Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.

Investment Thesis
Research

On balance, the picture is mixed: Zions Bancorporation NA is a small-cap financials business growing at a mature pace, with modest profitability, and a heavier debt load to watch. It trades at n/a earnings, which our model scores Unrated (0/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.

Analyst Ratings

What 29 Wall Street analysts covering ZION recommend (August 2026). Consensus is a useful sanity check — not a substitute for your own homework.

Hold
consensus · score 3.5 / 5 across 29 analysts
Strong Buy 5Buy 7Hold 14Sell 3Strong Sell 0

Analysts have turned more cautious over the last three months (-5 pts of buy ratings).

Latest SEC Filings

ZION's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen.

ZION — frequently asked questions

Is ZION a good stock to buy?

We don't give buy or sell advice. Review Zions Bancorporation NA's fundamentals, valuation, and 5-year financials on this page, then make your own decision — and consider a licensed professional.

Where does ZION's data come from?

Live price data plus real fundamentals and 5-year financials pulled directly from Zions Bancorporation NA's SEC filings — refreshed automatically, not hand-entered.

How is the 5-year projection for ZION calculated?

It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.

Is this ZION analysis financial advice?

No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell ZION. Always do your own research and consider a licensed professional.

Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.

Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.